Pilot Study to Evaluate the Restore Orthobiologic Implant in Rotator Cuff Tear Repair

July 1, 2016 updated by: DePuy International

A Prospective, Randomised Pilot Study to Determine the Variability of Early Clinical Outcome in Subjects Undergoing Full Thickness Rotator Cuff Tear Repair, When Augmented With or Without Porcine Small Intestine Submucosa (RESTORE)

Primary Endpoints:

Comparative evaluation of any differences between the two groups in change from baseline to the 3-month time point in terms of:

  • Functional recovery (patient-based) - using the Oxford Shoulder Score.
  • Functional recovery and early return of strength (pain, activities of daily living [ADL], range of motion [ROM], and power) - evaluated using the Constant Shoulder Assessment.
  • Functional recovery (pain and function - patient-based), evaluated using the American Shoulder and Elbow Surgeons (ASES) Shoulder Assessment - patient self-report section.
  • Region-specific Quality of Life - using the Western Ontario Rotator Cuff (WORC) Index.
  • Range of motion - assessed by goniometer recorded as part of the Constant Score.
  • Pain (taken from Pain visual analog scale [VAS] of the ASES Shoulder Assessment); and
  • Record of escape pain medication usage (recorded in a daily patient diary).

Secondary Endpoints:

Comparative evaluation of any difference between the two groups in change from baseline to the 6-week time point, in terms of:

  • Pain (taken from Pain VAS of the ASES Shoulder Assessment) and record of escape pain medication usage (recorded in a daily patient diary).

Comparative evaluation of any differences between the two groups in change from baseline to the 6-month time point, in terms of:

  • Functional recovery (patient-based) - using the Oxford Shoulder Score.
  • Functional recovery and early return of strength (pain, ADL, ROM, and power) - evaluated using the Constant Shoulder Assessment.
  • Functional recovery (pain and function - patient-based), evaluated using the ASES Shoulder Assessment - patient self-report section.
  • Region-specific Quality of Life - using the Western Ontario Rotator Cuff Index.
  • Range of motion - assessed by goniometer recorded as part of the Constant Score.
  • Pain (taken from Pain VAS of the ASES Shoulder Assessment) and record of escape pain medication usage (recorded in a patient diary).

Comparative evaluation of any difference between the two groups in change from baseline to the 6-week, 3, 6 and 12 month time points, in terms of health status - assessed by the EQ-5D instrument.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium, B-3000
        • U.Z. Gasthuis Berg
      • Liverpool, United Kingdom, L7 8XP
        • Royal Liverpool University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female subjects, aged 40 and above.
  • Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
  • Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures, and are willing to return to the hospital for all the required post-operative follow-ups.
  • Subjects whose clinical symptoms and diagnosis suggest that they have a full-thickness rotator cuff tear (which includes but is not limited to the supraspinatus), which is degenerate in nature.

Exclusion Criteria:

  • Subjects who, in the opinion of the Investigator, have an existing condition that would prevent them from fulfilling the requirements of the Clinical Investigation Plan. (This should be detailed in the Screening Log.)
  • Women who are pregnant.
  • Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
  • Subjects who have participated in a clinical study with an investigational product in the last 6 months.
  • Subjects who are currently known to be involved in any injury litigation claims relating to the shoulder being treated as part of the study.
  • Subjects with a known allergy to porcine material or who, for religious or other reasons, are unwilling to accept a porcine-derived implant.
  • Subjects who have undergone previous shoulder surgery (excluding purely-diagnostic arthroscopy).
  • Subjects with significant paralysis of the shoulder.
  • Subjects with inflammatory arthropathies.
  • Subjects with active joint or systemic infection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 1
Rotator cuff repair with RESTORE Porcine Small Intestine Submucosa patch (RESTORE SIS Patch) reinforcement
Surgical repair of torn rotator cuff with RESTORE Porcine Small Intestine Submucosa patch (RESTORE SIS Patch) reinforcement
ACTIVE_COMPARATOR: 2
Standard rotator cuff repair
Standard surgical repair of torn rotator cuff

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Difference demonstrated between two groups on the Oxford Shoulder Score from baseline to 3 months
Time Frame: 3 months
3 months
Difference demonstrated between two groups on the Constant Shoulder Assessment from baseline to 3 months
Time Frame: 3 months
3 months
Difference demonstrated between two groups on the ASES Shoulder Assessment from baseline to 3 months
Time Frame: 3 months
3 months
Difference demonstrated between two groups on the Western Ontario Rotator Cuff Index from baseline to 3 months
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Difference demonstrated between the two groups on the ASES Shoulder Assessment from baseline to 6 weeks.
Time Frame: 6 weeks
6 weeks
Difference demonstrated between the two groups on the ASES Shoulder Assessment from baseline to 6 months
Time Frame: 6 months
6 months
Difference demonstrated between 2 groups on EQ-5D from baseline to 6 weeks
Time Frame: 6 weeks
6 weeks
Difference demonstrated between the two groups on the Constant Shoulder Assessment from baseline to 6 months
Time Frame: 6 months
6 months
Difference demonstrated between the two groups on the Oxford Shoulder Score from baseline to 6 months
Time Frame: 6 months
6 months
Difference demonstrated between the two groups on the Western Ontario Rotator Cuff from baseline to 6 months
Time Frame: 6 months
6 months
Difference demonstrated between 2 groups on EQ-5D from baseline to 3 months
Time Frame: 3 months
3 months
Difference demonstrated between 2 groups on EQ-5D from baseline to 6 months
Time Frame: 6 months
6 months
Difference demonstrated between 2 groups on EQ-5D from baseline to 12 months
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2005

Primary Completion (ACTUAL)

February 1, 2007

Study Completion (ACTUAL)

April 1, 2015

Study Registration Dates

First Submitted

September 13, 2005

First Submitted That Met QC Criteria

September 13, 2005

First Posted (ESTIMATE)

September 21, 2005

Study Record Updates

Last Update Posted (ESTIMATE)

July 4, 2016

Last Update Submitted That Met QC Criteria

July 1, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CT 04/17

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe